title: Does drug-induced hypersensitivity syndrome elicit bullous pemphigoid?
authors.forename: Akiko
authors.initials: A
authors.lastname: Kijima
authors.forename: Shigeki
authors.initials: S
authors.lastname: Inui
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Nakamura
authors.forename: Satoshi
authors.initials: S
authors.lastname: Itami
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002220:Carbamazepine / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007555:Isoxazoles / Q000009:adverse effects; D008911:Minocycline / Q000009:adverse effects; D010391:Pemphigoid, Bullous / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D010612:Pharyngitis / Q000188:drug therapy; D013577:Syndrome; D013997:Time Factors; D016896:Treatment Outcome; D014277:Trigeminal Neuralgia / Q000188:drug therapy; D000078305:Zonisamide
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D002220:Carbamazepine; D000078305:Zonisamide; D008911:Minocycline